Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro
Shuyi Li, Yang Hui, Jiqiao Yuan, Ziqian Zhang, Xuyu Li, Nan Fang, Mingbao Lin, Qi Hou Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of ChinaCorrespondence: Mingbao Lin; Qi Hou Tel +86-10-63165192; +86-10-...
Saved in:
Main Authors: | Li S, Hui Y, Yuan J, Zhang Z, Li X, Fang N, Lin M, Hou Q |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/71c6ae6456f94e4d83394065b28f9221 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
by: Yong Suk Jo, et al.
Published: (2021) -
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
by: Almeshari MA, et al.
Published: (2021) -
Multiple Components Rapidly Screened from Perilla Leaves Attenuate Asthma Airway Inflammation by Synergistic Targeting on Syk
by: Yang H, et al.
Published: (2020) -
Effectiveness of Telemonitoring for Respiratory and Systemic Symptoms of Asthma and COPD: A Narrative Review
by: Esther Metting, et al.
Published: (2021) -
Serum CYR61 Is Associated With Airway Inflammation and Is a Potential Biomarker for Severity in Chronic Obstructive Pulmonary Disease
by: Zhu-Xia Tan, et al.
Published: (2021)